Arete Wealth Advisors, LLC Adma Biologics, Inc. Transaction History
Arete Wealth Advisors, LLC
- $1.41 Billion
- Q2 2025
A detailed history of Arete Wealth Advisors, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 17,976 shares of ADMA stock, worth $262,269. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,976Holding current value
$262,269% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
403Shares Held
197MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$312 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$272 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$187 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86.3 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...